These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Monitoring high-dose heparinization during cardiopulmonary by-pass--a comparison between prothrombinase-induced clotting time (PiCT) and two chromogenic anti-factor Xa activity assays. Raivio P; Kuitunen A; Petäjä J; Ilveskero S; Lassila R Thromb Haemost; 2008 Feb; 99(2):427-34. PubMed ID: 18278195 [TBL] [Abstract][Full Text] [Related]
24. The effect of two different doses of aprotinin on hemostasis in cardiopulmonary bypass surgery: similar transfusion requirements and blood loss. Santamaría A; Mateo J; Oliver A; Litvan H; Murillo J; Souto JC; Fontcuberta J Haematologica; 2000 Dec; 85(12):1277-84. PubMed ID: 11114135 [TBL] [Abstract][Full Text] [Related]
25. Tranexamic acid and aprotinin in primary cardiac operations: an analysis of 220 cardiac surgical patients treated with tranexamic acid or aprotinin. Dietrich W; Spannagl M; Boehm J; Hauner K; Braun S; Schuster T; Busley R Anesth Analg; 2008 Nov; 107(5):1469-78. PubMed ID: 18931201 [TBL] [Abstract][Full Text] [Related]
26. Comparison of the inflammatory response between miniaturized and standard CPB circuits in aortic valve surgery. Bical OM; Fromes Y; Gaillard D; Fischer M; Ponzio O; Deleuze P; Gerhardt MF; Trivin F Eur J Cardiothorac Surg; 2006 May; 29(5):699-702. PubMed ID: 16520053 [TBL] [Abstract][Full Text] [Related]
27. A closed perfusion system with heparin coating and centrifugal pump improves cardiopulmonary bypass biocompatibility in elderly patients. Lindholm L; Westerberg M; Bengtsson A; Ekroth R; Jensen E; Jeppsson A Ann Thorac Surg; 2004 Dec; 78(6):2131-8; discussion 2138. PubMed ID: 15561050 [TBL] [Abstract][Full Text] [Related]
28. Increased prothrombotic state lasting as long as one month after on-pump and off-pump coronary surgery. Parolari A; Mussoni L; Frigerio M; Naliato M; Alamanni F; Galanti A; Fiore G; Veglia F; Tremoli E; Biglioli P; Camera M J Thorac Cardiovasc Surg; 2005 Aug; 130(2):303-8. PubMed ID: 16077391 [TBL] [Abstract][Full Text] [Related]
29. Clinical study of biocompatibility between open and closed heparin-coated cardiopulmonary bypass circuits. Tanaka H; Oshiyama T; Narisawa T; Mori T; Masuda M; Kishi D; Kitou T; Miyazima S J Artif Organs; 2003; 6(4):245-52. PubMed ID: 14691666 [TBL] [Abstract][Full Text] [Related]
30. The effects of aprotinin and tranexamic acid on thrombin generation and fibrinolytic response after cardiac surgery. Kuitunen A; Hiippala S; Vahtera E; Rasi V; Salmenperä M Acta Anaesthesiol Scand; 2005 Oct; 49(9):1272-9. PubMed ID: 16146463 [TBL] [Abstract][Full Text] [Related]
31. Off-pump coronary artery bypass operation does not increase procoagulant and fibrinolytic activity: preliminary results. Englberger L; Immer FF; Eckstein FS; Berdat PA; Haeberli A; Carrel TP Ann Thorac Surg; 2004 May; 77(5):1560-6. PubMed ID: 15111143 [TBL] [Abstract][Full Text] [Related]
32. Coagulation-fibrinolysis changes during off-pump bypass: effect of two heparin doses. Paparella D; Semeraro F; Scrascia G; Galeone A; Ammollo CT; Kounakis G; de Luca Tupputi Schinosa L; Semeraro N; Colucci M Ann Thorac Surg; 2010 Feb; 89(2):421-7. PubMed ID: 20103314 [TBL] [Abstract][Full Text] [Related]
33. The impact of cardiac ischemia and reperfusion on markers of activated haemostasis and fibrinolysis during cardiopulmonary bypass: comparison of plasma levels in arterial and coronary venous blood. Kalweit G; Bach J; Huwer H; Winning J; Hellstern P Thromb Res; 2005; 116(1):33-9. PubMed ID: 15850606 [TBL] [Abstract][Full Text] [Related]
34. Totally minimized extracorporeal circulation: an important benefit for coronary artery bypass grafting in Jehovah's witnesses. Vaislic C; Bical O; Farge C; Gaillard D; Ponzio O; Ollivier Y; Abdelmoumen Y; Robine B; Souffrant G; Bouharaoua T Heart Surg Forum; 2003; 6(5):307-10. PubMed ID: 14721799 [TBL] [Abstract][Full Text] [Related]
35. Cardiopulmonary bypass parameters and hemostatic response to cardiopulmonary bypass in infants versus children. Eisses MJ; Chandler WL J Cardiothorac Vasc Anesth; 2008 Feb; 22(1):53-9. PubMed ID: 18249331 [TBL] [Abstract][Full Text] [Related]
36. The changes and effects of the plasma levels of tumor necrosis factor after coronary artery bypass surgery with cardiopulmonary bypass. Abacilar F; Dogan OF; Duman U; Ucar I; Demircin M; Ersoy U; Dogan R; Boke E Heart Surg Forum; 2006; 9(4):E703-9. PubMed ID: 16844625 [TBL] [Abstract][Full Text] [Related]
37. Low doses of aprotinin in aortocoronary bypass surgery--advantages and disadvantages. Golański R; Golański J; Chizyński K; Iwaszkiewicz A; Zasłonka J; Pietrucha T; Chrul S; Watała C Med Sci Monit; 2000; 6(4):722-8. PubMed ID: 11208399 [TBL] [Abstract][Full Text] [Related]
38. Effects of nafamostat mesilate on platelets and coagulofibrinolysis during cardiopulmonary bypass surgery. Tanaka K; Kondo C; Takagi K; Sato T; Yada I; Yuasa H; Kusagawa M ASAIO J; 1993; 39(3):M545-9. PubMed ID: 8268595 [TBL] [Abstract][Full Text] [Related]
39. Effect of polymer coating (poly 2-methoxyethylacrylate) of the oxygenator on hemostatic markers during cardiopulmonary bypass in children. Eisses MJ; Geiduschek JM; Jonmarker C; Cohen GA; Chandler WL J Cardiothorac Vasc Anesth; 2007 Feb; 21(1):28-34. PubMed ID: 17289476 [TBL] [Abstract][Full Text] [Related]
40. The influence of perioperative coagulation status on postoperative blood loss in complex cardiac surgery: a prospective observational study. Karkouti K; McCluskey SA; Syed S; Pazaratz C; Poonawala H; Crowther MA Anesth Analg; 2010 Jun; 110(6):1533-40. PubMed ID: 20435945 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]